HC Wainwright & Co. Reiterates Buy on Xeris Biopharma Holdings, Maintains $10 Price Target

XERIS PHARMACEUTICALS INC -4.36%

XERIS PHARMACEUTICALS INC

XERS

5.48

-4.36%

HC Wainwright & Co. analyst Brandon Folkes reiterates Xeris Biopharma Holdings (NASDAQ: XERS) with a Buy and maintains $10 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via